Thum; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thum; Thomas.The latest application filed is for "treatment of heart failure in human subjects".

Company Profile

9.19.30

Thum; Thomas - Hannover DE
Thum; Thomas - Wuerzburg N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Heart Failure In Human Subjects App 20220243204 - Thum; Thomas ; et al.	2022-08-04
LncRNAs for therapy and diagnosis of cardiac hypertrophy Grant 11,371,043 - Thum , et al. June 28, 2	2022-06-28
Compound for treatment of heart failure App 20220162597 - Thum; Thomas ; et al.	2022-05-26
Compound for treatment of heart failure Grant 11,208,651 - Thum , et al. December 28, 2	2021-12-28
LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling Grant 11,186,838 - Thum , et al. November 30, 2	2021-11-30
Natural compounds and fibrosis Grant 11,185,539 - Thum , et al. November 30, 2	2021-11-30
Improved Compound for Treatment of Heart Failure App 20210180054 - Thum; Thomas ; et al.	2021-06-17
MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes App 20210113603 - Thum; Thomas ; et al.	2021-04-22
Lncrnas For Therapy And Diagnosis Of Cardiac Hypertrophy App 20200165604 - THUM; THOMAS ; et al.	2020-05-28
Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients Grant 10,584,383 - Thum , et al.	2020-03-10
MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes App 20200069720 - Thum; Thomas ; et al.	2020-03-05
IncRNAS FOR THERAPY AND DIAGNOSIS OF ANGIOGENESIS App 20190376061 - THUM; Thomas ; et al.	2019-12-12
Natural Compounds And Fibrosis App 20190350923 - Thum; Thomas ; et al.	2019-11-21
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 10,434,117 - Thum , et al. O	2019-10-08
The LNCRNA MEG3 for Therapy and Diagnosis of Cardiac Remodelling App 20190136236 - THUM; Thomas ; et al.	2019-05-09
LncRNAs for therapy and diagnosis of angiogenesis Grant 10,221,417 - Thum , et al.	2019-03-05
MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes App 20180360866 - Thum; Thomas ; et al.	2018-12-20
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 10,028,974 - Thum , et al. July 24, 2	2018-07-24
MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES App 20170304347 - Thum; Thomas ; et al.	2017-10-26
A Circulating Non-coding Rna As Predictor Of Mortality In Patients With Acute Kidney Injury App 20170240969 - THUM; Thomas ; et al.	2017-08-24
Lncrnas For Therapy And Diagnosis Of Cardiac Hypertrophy App 20170183652 - THUM; Thomas ; et al.	2017-06-29
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 9,663,788 - Thum , et al. May 30, 2	2017-05-30
Mitochondrial Non-Coding RNAs for Predicting Disease Progression in Heart Failure and Myocardial Infarction Patients App 20170114409 - THUM; Thomas ; et al.	2017-04-27
Incrnas For Therapy And Diagnosis Of Angiogenesis App 20170037405 - THUM; Thomas ; et al.	2017-02-09
miRNA-212/132 family as a therapeutic target Grant 9,388,411 - Thum , et al. July 12, 2	2016-07-12
MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES App 20160177302 - Thum; Thomas ; et al.	2016-06-23
Analysis For Takotsubo Cardiomyopathy By Means Of Differentially Regulated Microrna Molecules App 20160177391 - Thum; Thomas ; et al.	2016-06-23
Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 9,220,722 - Thum , et al. December 29, 2	2015-12-29
Microrna Profiles In The Diagnosis Of Multiple Sclerosis App 20150267254 - Thum; Thomas ; et al.	2015-09-24
MicroRNA (miRNA) for the diagnosis and treatment of heart diseases Grant 8,906,870 - Thum , et al. December 9, 2	2014-12-09
THE miRNA-212/132 FAMILY AS A THERAPEUTIC TARGET App 20140275220 - Thum; Thomas ; et al.	2014-09-18
MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES App 20140121264 - Thum; Thomas ; et al.	2014-05-01
MicroRNA-24 Grant 8,691,783 - Thum , et al. April 8, 2	2014-04-08
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 8,592,389 - Thum , et al. November 26, 2	2013-11-26
MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES App 20130018084 - Thum; Thomas ; et al.	2013-01-17
Device And Method For Analysis Of Kidney Failure App 20120202201 - Thum; Thomas ; et al.	2012-08-09
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes Grant 8,236,777 - Thum , et al. August 7, 2	2012-08-07
Microrna-24 App 20120180147 - Thum; Thomas ; et al.	2012-07-12
MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes App 20110071211 - Thum; Thomas ; et al.	2011-03-24
Microrna (mirna) For The Diagnosis And Treatment Of Heart Diseases App 20100010073 - Thum; Thomas ; et al.	2010-01-14
Methods and agents for treating cardiovascular diseases App 20060258632 - Borlak; Jurgen ; et al.	2006-11-16
Methods and agents for treating cardiovascular diseases App 20040110733 - Borlak, Jurgen ; et al.	2004-06-10
PCR reaction mixture for fluorescence-based gene expression and gene mutation analyses App 20020058255 - Thum, Thomas ; et al.	2002-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.